…and then making the technology affordable
Among brain SRS technology choices, clinicians at ARTC selected Leksell Gamma Knife Perfexion for its speed and gold standard accuracy, and because it’s a system dedicated to intracranial targets. To achieve this treatment goal, ARTC partnered with DLL on the purchase.
“We offered a financing solution to Dr. Chung and his associates, in order to better allocate their capital budget, and ultimately improve the standard of care,” said Ian Dickson, Chief Financial Officer at Elekta.
“DLL stands apart from their competitors, because of their extensive knowledge of the dynamic healthcare environment and commitment to achieving our business goals.